Analyst Ratings For Insulet (NASDAQ:PODD)
Today, Barclays raised its price target on Insulet (NASDAQ:PODD) to per share.
Some recent analyst ratings include
- 1/8/2018-Raymond James Financial Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 11/1/2017-Canaccord Genuity Upgrade from a “Hold ” rating to a ” Buy” rating.
- 10/12/2017-Leerink Swann Reiterated Rating of Outperform.
- On 11/13/2017 James C. Mullen, Director, bought 2,500 with an average share price of $67.45 per share and the total transaction amounting to $168,625.00.
- On 9/6/2017 Charles Alpuche, EVP, bought 2,500 with an average share price of $58.08 per share and the total transaction amounting to $145,200.00.
- On 5/16/2017 Michael P. Spears, SVP, bought 2,500 with an average share price of $40.59 per share and the total transaction amounting to $101,475.00.
- On 5/11/2017 Bradley A. Thomas, EVP, bought 3,000 with an average share price of $38.69 per share and the total transaction amounting to $116,070.00.
- On 5/11/2017 Jessica Hopfield, Director, bought 2,580 with an average share price of $38.68 per share and the total transaction amounting to $99,794.40.
- On 5/1/2017 David A. Lemoine, Director, sold 1,524 with an average share price of $43.40 per share and the total transaction amounting to $66,141.60.
- On 3/13/2017 Regina O. Sommer, Director, sold 40,000 with an average share price of $45.00 per share and the total transaction amounting to $1,800,000.00.
Recent Trading Activity for Insulet (NASDAQ:PODD)
Shares of Insulet closed the previous trading session at 80.00 up +2.26 2.91% with 82.29000091552734 shares trading hands.